Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Yuejuan Cheng is a leading authority in the diagnosis and treatment of pancreatic neuroendocrine neoplasms (pNENs), a rare and highly heterogeneous group of tumors. Her most impactful work centers on establishing standardized clinical frameworks for these complex malignancies, which arise from pluripotent stem cells in the pancreas and represent roughly 3% of all pancreatic tumors. Notably, Dr. Cheng spearheaded the "Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms" (2023), a seminal guideline that harmonizes diagnostic criteria and therapeutic strategies amid the rising global incidence of pNENs. This consensus, already cited 3 times, reflects her pivotal role in translating cutting-edge research into actionable clinical protocols. By addressing the unique challenges of these tumors—from their biological diversity to evolving treatment paradigms—Dr. Cheng has advanced precision medicine in neuroendocrine oncology. Her work not only improves patient outcomes but also serves as a critical resource for clinicians and researchers navigating this rare disease landscape. Through her leadership, she continues to shape the future of pNEN management, bridging gaps between molecular understanding and real-world practice.